introduct
disproportion
affect
comorbid
elderli
hypertens
common
preexist
condit
amongst
patient
upregul
reninangiotensinaldosteron
system
raa
common
hypertens
patient
may
promot
inflamm
ensu
cytokin
storm
unknown
whether
raa
inhibit
inhibitor
angiotensinreceptor
blocker
arb
harm
benefici
among
hospit
patient
carri
diagnosi
hypertens
discharg
deceas
cohort
overal
mortal
significantli
increas
vs
among
patient
hypertens
howev
adjust
age
effect
hypertens
mortal
greatli
diminish
reduct
oddsratio
half
complet
disappear
adjust
major
covari
mortal
rate
lower
hypertens
patient
prescrib
arb
compar
antihypertens
agent
unadjust
analys
raa
inhibitor
therapi
appear
protect
compar
antihypertens
agent
conclus
result
limit
retrospect
natur
studi
potenti
confound
data
argu
harm
effect
raa
inhibit
support
hfsaahaacc
joint
statement
recommend
continu
arb
therapi
hypertens
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
elderli
patient
especi
comorbid
condit
disproportion
affect
caus
agent
hypertens
common
preexist
condit
among
patient
earli
report
note
associ
hypertens
increas
mortal
upregul
reninangiotensinaldosteron
system
raa
occur
hypertens
patient
may
promot
inflamm
ensu
cytokin
storm
spike
glycoprotein
gain
entri
cell
bind
angiotensin
convert
enzym
epitheli
cell
lung
intestin
kidney
subsequ
downregul
surfac
result
accumul
angiotensin
ii
angii
effect
vasoconstrict
inflamm
fibrosi
pharmacolog
inhibit
raa
inhibitor
angiotensinreceptor
blocker
arb
increas
express
could
harm
benefici
given
concern
physician
may
tempt
alter
antihypertens
therapi
although
abrupt
withdraw
raa
inhibitor
associ
cardiac
instabl
patient
cardiomyopathi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
perform
retrospect
multicent
conveni
sampl
studi
patient
hospit
confirm
within
hackensack
meridian
health
network
largest
healthcar
provid
new
jersey
demograph
clinic
characterist
treatment
outcom
manual
abstract
electron
health
record
institut
review
board
approv
obtain
databas
subject
inform
consent
waiv
analysi
conduct
secondari
use
deidentifi
data
fisher
exact
test
logist
regress
perform
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
heart
failur
societi
america
hfsa
american
heart
associ
aha
american
colleg
cardiolog
acc
releas
joint
statement
recommend
continu
use
arb
inhibitor
hypertens
patient
retrospect
realworld
review
hospit
patient
found
hypertens
worsen
mortal
correct
age
key
factor
identifi
harm
effect
raa
inhibit
suggest
possibl
benefit
evid
hypertens
patient
higher
angii
level
contribut
proinflammatori
state
therefor
arb
decreas
angii
product
antagon
action
block
receptor
might
suppress
inflammatori
state
chines
retrospect
report
also
note
lower
inhospit
mortal
raa
inhibitor
compar
antihypertens
agent
result
limit
retrospect
natur
studi
data
argu
harm
effect
raa
inhibit
support
hfsaahaacc
joint
statement
recommend
continu
arb
therapi
hypertens
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
author
wish
thank
nurs
data
manag
physician
care
patient
assist
abstract
clinic
data
author
complet
icmj
uniform
disclosur
form
wwwicmjeorgcoidisclosurepdf
declar
support
organ
submit
work
financi
relationship
organ
might
interest
submit
work
previou
three
year
relationship
activ
could
appear
influenc
submit
work
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
